Status:
UNKNOWN
The Relationships of Resistance Exercise, Walking, Myokine Secretion, Sarcopenia, Muscle Loss, Quality of Life, and Predictors in Cancer Patients Receiving Chemoradiotheray
Lead Sponsor:
Taipei Medical University
Conditions:
Cancer
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Cancer is the first most common cause of death in Taiwan. The application of surgery and chemoradiotherapy are used for treatment of patients with cancer. However, loss of muscle mass, low muscle stre...
Detailed Description
Cancer is the first most common cause of death in Taiwan. The application of surgery and chemoradiotherapy are used for treatment of patients with cancer. However, loss of muscle mass, low muscle stre...
Eligibility Criteria
Inclusion
- Cancer patients receiving chemoradiotherap
- age 20-70 years old
- participants who are available for doing resistance exercise and/or walking after physical assessment by physician
- education level \>=elementary school
Exclusion
- Participants can't speak Mandarin, Taiwanese, or Hakka language.
Key Trial Info
Start Date :
December 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06203301
Start Date
December 2 2021
End Date
September 30 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taipei Taiwan, Taiwan, 110301